Back to the main directory
Event / Equity
- Espresso | Oeneo | Hold | Fairly valued after takeover attempt by Kepler Cheuvreux
- Espresso | H & R | Reduce | Poor Q4 preliminaries by Kepler Cheuvreux
- Espresso | FNAC-Darty | Buy | Reasonably confident for 2020 by Kepler Cheuvreux
- Espresso | Neinor Homes | Reduce | Rental residential, here we go by Kepler Cheuvreux
- Espresso | Abivax | Buy | Clinical progress of ABX196 by Kepler Cheuvreux
- Espresso | Sunrise Communications | Buy | Solid operational momentum by Kepler Cheuvreux
- Espresso | Ence | Buy | Q4 results broadly line by Kepler Cheuvreux
- Espresso | Hoegh LNG | Buy | Numbers in line, no news on contracts by Kepler Cheuvreux
- Espresso | EVN | Hold | Q1 2019/20 results by Kepler Cheuvreux
- Espresso | AB InBev | Buy | Guidance for 2-5% EBITDA growth by Kepler Cheuvreux
- Espresso | IMCD | Buy | Solid finish to the year by Kepler Cheuvreux
- Espresso | SEB | Hold | Results in line, update on COVID-19 by Kepler Cheuvreux
- Espresso | Ekinops | Buy | +43% YOY EBITDA by Kepler Cheuvreux
- Espresso | Vidrala | Buy | Strong Q4, above consensus by Kepler Cheuvreux
- Espresso | Amplitude Surgical | Hold | Novastep quickens the pace by Kepler Cheuvreux
- Espresso | TechnipFMC | Hold | Soft 2020 subsea margin guidance by Kepler Cheuvreux
- Espresso | Bayer | Hold | Outlook a little weak, but glyphosate cases slowing by Kepler Cheuvreux
- Espresso | Seadrill | Buy | Q4 in line, guidance and fleet update on the soft side by Kepler Cheuvreux
- Espresso | Frontline | Buy | Below consensus, but that is consensus fault by Kepler Cheuvreux
- Espresso | Hunting | Buy | Mixed H2 earnings, higher dividend + share buyback, uncertain 2020 by Kepler Cheuvreux
- Espresso | Avance Gas | Buy | Q4 EPS in line while twice the dividend expected by consensus by Kepler Cheuvreux
- Espresso | Engie | Buy | FY 2019 results first take by Kepler Cheuvreux
- Espresso | Valneva | Hold | FY 2019 results by Kepler Cheuvreux
- Espresso | OHL | Reduce | Operating in line, bottom miss, CF beat, and unambitious guidance by Kepler Cheuvreux
- Espresso | Grifols | Hold | Q4 results: solid sales performance driven by Bioscience by Kepler Cheuvreux